Ingenus Pharms Llc Company Profile
What is the competitive landscape for INGENUS PHARMS LLC
INGENUS PHARMS LLC has sixty approved drugs.
Drugs and US Patents for Ingenus Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingenus Pharms Llc | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 210623-001 | May 3, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ingenus Pharms Llc | NADOLOL | nadolol | TABLET;ORAL | 210786-003 | Jun 1, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ingenus Pharms Llc | FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 209271-001 | Dec 11, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

